V. Tulasi

Glycogen synthase kinase 3: more than a namesake

A. Ray, G. Rayasam, V. Tulasi, 2009, British journal of pharmacology.

Fatty acid receptors as new therapeutic targets for diabetes

G. Rayasam, V. Tulasi, J. A. Davis, 2007, Expert opinion on therapeutic targets.

An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

Lucinda V. Jackson, P. Lockey, D. Norman, 2015, Journal of Medicinal Chemistry.

Identification of berberine as a novel agonist of fatty acid receptor GPR40

A. Ray, G. Rayasam, V. Tulasi, 2010, Phytotherapy research : PTR.

Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.

A. Ray, V. Tulasi, J. A. Davis, 2017, Bioorganic & medicinal chemistry letters.

An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

Lucinda V. Jackson, P. Lockey, D. Norman, 2015, Journal of Medicinal Chemistry.